PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 64 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $13,000 | +30.0% | 20,800 | -7.1% | 0.00% | – |
| Q2 2016 | $10,000 | -58.3% | 22,400 | -3.0% | 0.00% | – |
| Q1 2016 | $24,000 | -67.1% | 23,100 | -6.1% | 0.00% | – |
| Q4 2015 | $73,000 | -6.4% | 24,600 | 0.0% | 0.00% | – |
| Q3 2015 | $78,000 | -75.4% | 24,600 | -54.1% | 0.00% | – |
| Q2 2015 | $317,000 | -36.0% | 53,600 | -5.4% | 0.00% | -100.0% |
| Q1 2015 | $495,000 | 0.0% | 56,648 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $495,000 | +153.8% | 56,648 | +123.0% | 0.00% | – |
| Q3 2014 | $195,000 | -14.5% | 25,400 | 0.0% | 0.00% | – |
| Q2 2014 | $228,000 | +88.4% | 25,400 | 0.0% | 0.00% | – |
| Q1 2014 | $121,000 | +98.4% | 25,400 | 0.0% | 0.00% | – |
| Q4 2013 | $61,000 | -12.9% | 25,400 | -0.8% | 0.00% | – |
| Q3 2013 | $70,000 | +9.4% | 25,600 | +44.3% | 0.00% | – |
| Q2 2013 | $64,000 | – | 17,735 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|